-
1Academic Journal
المؤلفون: Cimpoieş, D.G., Чимпоеш, Д., Crudu, L., Racul, A.D., Ракул, А.
المصدر: Modern paradigms in the development of the national and world economy
مصطلحات موضوعية: Agricultural land, cadastral code, transactions evaluation, spatial econometric model, adjacency matrix
وصف الملف: application/pdf
-
2Academic Journal
المؤلفون: Danilov, I., Cimpoieş, D.G., Чимпоеш, Д., Racul, A.D., Ракул, А.
المصدر: Competitivitatea şi inovarea în economia cunoaşterii (Ediţia a 27-a, Volumul 1)
مصطلحات موضوعية: teaching staff performance, agronomic profile, Educational policies, higher education institutions
وصف الملف: application/pdf
-
3Academic Journal
المؤلفون: Novac, G., Racul, A.D., Ракул, А.
المصدر: Revista de Silvicultura si Cinegetica (52) 10-20
مصطلحات موضوعية: scientific reserves, financial report, data envelopment analysis, managerial performance
وصف الملف: application/pdf
Relation: https://ibn.idsi.md/vizualizare_articol/193922; urn:issn:15832112
-
4Academic Journal
المؤلفون: Peşteanu, A.T., Пештяну, А., Cimpoieş, D.G., Чимпоеш, Д., Cumpanici, A., Calestru, O., Racul, A.D., Ракул, А.
المصدر: Modern Trends in the Agricultural Higher Education
مصطلحات موضوعية: area, projection, specific production, Thinning, volume
وصف الملف: application/pdf
-
5Academic Journal
المؤلفون: Reșitca, R., Racul, A.D., Ракул, А.
المصدر: Competitivitatea şi inovarea în economia cunoaşterii (Ediţia a 26-a)
مصطلحات موضوعية: Efficiency analysis, agronomic profile, data envelopment analysis, Educational policies, multitasking
وصف الملف: application/pdf
-
6Academic Journal
المؤلفون: Stici, V., Burlacu, S., Enciu, V.Z., Racul, A.D., Ракул, А.
المصدر: Microbial Biotechnology (Ediția 5)
مصطلحات موضوعية: pork meat, malondialdehyde, thiobarbituric acid, Acidity, conductivity, oxidationreduction potential
وصف الملف: application/pdf
-
7Academic Journal
المؤلفون: Cimpoieş, D.G., Чимпоеш, Д., Racul, A.D., Ракул, А., Reșitca, R.
المصدر: 30 years of economic reforms in the Republic of Moldova: economic progress via innovation and competitiveness (Vol.3)
مصطلحات موضوعية: academic performance, agronomic profile, Educational policies, Higher education institutions
وصف الملف: application/pdf
-
8Academic Journal
المؤلفون: Cimpoieş, D.G., Чимпоеш, Д., Racul, A.D., Ракул, А., Danilov, I.
المصدر: 30 years of economic reforms in the Republic of Moldova: economic progress via innovation and competitiveness (Vol.3)
مصطلحات موضوعية: rural area, spatial econometrics, opportunity price, land transactions
وصف الملف: application/pdf
-
9Academic Journal
المؤلفون: Cimpoieş, D.G., Чимпоеш, Д., Racul, A.D., Ракул, А., Reșitca, R.
المصدر: The Collection. (Ediția 1)
مصطلحات موضوعية: performanţă academică, DEA, institute de cercetare, sectorul agrar
وصف الملف: application/pdf
-
10Academic Journal
المؤلفون: S. Rakul A., K. Pozdnyakov V., R. Eloev A., С. Ракул А., К. Поздняков В., Р. Елоев А.
المصدر: Cancer Urology; Том 17, № 2 (2021); 34-45 ; Онкоурология; Том 17, № 2 (2021); 34-45 ; 1996-1812 ; 1726-9776
مصطلحات موضوعية: kidney cancer, partial nephrectomy, complication, laparoscopic partial nephrectomy, robot-assisted partial nephrectomy, рак почки, резекция почки, осложнение, лапароскопическая резекция почки, робот-ассистированная резекция почки
وصف الملف: application/pdf
Relation: https://oncourology.abvpress.ru/oncur/article/view/1419/1267; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1419/967; Kates M., Badalato G.M., Pitman M., McKiernan J.M. Increased risk of overall and cardiovascular mortality after radical nephrectomy for renal cell carcinoma 2 cm or less. J Urol 2011;186(4):1247-53. DOI:10.1016/j.juro.2011.05.054.; Kaushik D., Kim S.P., Childs M.A. et al. Overall survival and development of stage IV chronic kidney disease in patients undergoing partial and radical nephrectomy for benign renal tumors. Eur Urol 2013;64(4):600-6. DOI:10.1016/j.eururo.2012.12.023.; Ljungberg B., Bensalah K., Canfield S. et al. EAU guidelines on renal cell carcinoma: 2014 update. Eur Urol 2015;67(5):913-24. DOI:10.1016/j.eururo.2015.01.005.; Campbell S., Uzzo R.G., Allaf M.E. et al. Renal mass and localized renal cancer: AUA guideline. J Urol 2017;198(3):520-9. DOI:10.1016/j.juro.2017.04.100.; Porpiglia F., Mari A., Bertolo R. et al. Partial nephrectomy in clinical T1b renal tumors: multicenter comparative study of open, laparoscopic and robot-assisted approach (the record project). Urology 2016;89:45-51. DOI:10.1016/j.urology.2015.08.049.; Furukawa J., Kanayama H., Azuma H. et al. “Trifecta” outcomes of robot-assisted partial nephrectomy: a large Japanese multicenter study. J Clin Oncol 2020;25(2):347-53. DOI:10.1007/s10147-019-01565-0.; Choi J.E., You J.H., Kim D.K. et al. Comparison of perioperative outcomes between robotic and laparoscopic partial nephrectomy: a systematic review and meta-analysis. Eur Urol 2015;67(5):891-901. DOI:10.1016/j.eururo.2014.12.028.; Cacciamani G., Medina L.G., Gill T. et al. Impact of surgical factors on robotic partial nephrectomy outcomes: comprehensive systematic review and metaanalysis. J Urol 2018;200(2):258-74. DOI:10.1016/j.juro.2017.12.086.; Van Poppel H., Da Pozzo L., Albrecht W. et al. A prospective randomized EORTC intergroup phase 3 study comparing the complications of elective nephronsparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur Urol 2007;51(6):1606-15. DOI:10.1016/j.eururo.2006.11.013.; Rosenthal R., Hoffmann H., Clavien P.A. et al. Definition and Classification of intraoperative complications (CLASSIC): delphi study and pilot evaluation. J Surg 2015;39(7):1663-71. DOI:10.1007/s00268-015-3003-y.; Clavien P.A., Barkun J., de Oliveira M.L. et al. The Clavien-Dindo classification of surgical complications: five year experience. Ann Surg 2009;250(2):187-96. DOI:10.1097/SLA.0b013e3181b13ca2.; Larson J.A., Kaouk J.H., Stifelman M.D. et al. Nonmodifiable factors and complications contribute to length of stay in robot-assisted partial nephrectomy. J Endourol 2015;29(4):422-9. DOI:10.1089/end.2014.0424.; Larcher A., Fossati N., Mistretta F. et al. Long-term oncologic outcomes of laparoscopic renal cryoablation as primary treatment for small renal masses. Urol Oncol 2015;33(1):22.e1-9. DOI:10.1016/j.urolonc.2014.09.003.; Arora S., Keeley J., Pucheril D. et al. What is the hospital volume threshold to optimize inpatient complication rate after partial nephrectomy? Urol Oncol 2018;36(7):339.e17-23. DOI:10.1016/j.urolonc.2018.04.009.; Hadjipavlou M., Khan F., Fowler S. et al. Partial vs radical nephrectomy for T1 renal tumors: an analysis from the British association of urological surgeons nephrectomy audit. BJU Int 2016;117(1):62-71. DOI:10.1111/bju.13114.; Bigot P., Hetet J.F., Bernhard J.C. et al. Nephron-sparing surgery for renal tumors measuring more than 7 cm: morbidity and functional and oncological outcomes. Clin Genitourin Cancer 2014;12(1):e19-27. DOI:10.1016/j.clgc.2013.09.004.; Tomaszewski J.J., Cung B., Smaldone M.C. et al. Renal pelvic anatomy is associated with incidence, grade, and need for intervention for urine leak following partial nephrectomy. Eur Urol 2014;66(5):949-55. DOI:10.1016/j.eururo.2013.10.009.; Tomaszewski J.J., Smaldone M.C., Cung B. et al. Internal validation of the renal pelvic score: a novel marker of renal pelvic anatomy that predicts urine leak after partial nephrectomy. Urology 2014;84(2):351-7. DOI:10.1016/j.urology.2014.05.001.; Kim S.P., Campbell S.C., Gill I. et al. Collaborative review of risk benefit trade-offs between partial and radical nephrectomy in the management of anatomically complex renal masses. Eur Urol 2017;72(1):64-75. DOI:10.1016/j.eururo.2016.11.038.; Banapour P., Abdelsayed G.A., Bider-Canfield Z. et al. Nephrometry score matched robotic vs. laparoscopic vs. open partial nephrectomy. J Robot Surg 2018;12(4):679-85. DOI:10.1007/s11701-018-0801-x.; Jang H.J., Song W., Suh Y.S. et al. Comparison of perioperative outcomes of robotic versus laparoscopic partial nephrectomy for complex renal tumors (RENAL nephrometry score of 7 or higher). Korean J Urol 2014;55(12):808-13. DOI:10.4111/kju.2014.55.12.808.; Lista G., Buffi N.M., Lughezzani G. et al. Margin, ischemia, and complications system to report perioperative outcomes of robotic partial nephrectomy: a European Multicenter Observational Study (EMOS project). Urology 2015;85(3):589-95. DOI:10.1016/j.urology.2014.09.068.; Mathieu R., Verhoest G., Droupy S. et al. Predictive factors of complications after robot-assisted laparoscopic partial nephrectomy: a retrospective multicentre study. BJU Int 2013;112(4):E283-9. DOI:10.1111/bju.12222.; Buffi N.M., Saita A., Lughezzani G. et al. Robot-assisted partial nephrectomy for complex (PADUA Score >10) tumors: techniques and results from a multicenter experience at four high-volume centers. Eur Urol 2020;77(1):95-100. DOI:10.1016/j.eururo.2019.03.006.; Krane L.S., Manny T.B., Mufarrij P.W. et al. Does experience in creating a robot-assisted partial nephrectomy (RAPN) programme in an academic centre impact outcomes or complication rate? BJU Int 2013;112(2):207-15. DOI:10.1111/bju.12160.; https://oncourology.abvpress.ru/oncur/article/view/1419
-
11Academic Journal
المؤلفون: Danilov, I., Cercel, I., Черчел, И., Racul, A.D., Ракул, А.
المصدر: Perspectivele şi Problemele Integrării în Spaţiul European al Cercetării şi Educaţiei (Vol.7, Partea 1)
مصطلحات موضوعية: непараметрический метод, сельская местность, рейтинг, TFP, nonparametric method, rural area, rating
وصف الملف: application/pdf
-
12Academic Journal
المؤلفون: Buzulan, M., Litvin, A., Racul, A.D., Ракул, А.
المصدر: Perspectivele şi Problemele Integrării în Spaţiul European al Cercetării şi Educaţiei (Vol.7, Partea 1)
مصطلحات موضوعية: consolidare funciară, eficienţă tehnică, arendă, gradul de comercializare, Land consolidation, Technical efficiency, leasing, degree of commercialization
وصف الملف: application/pdf
-
13Academic Journal
المؤلفون: Reșitca, R., Cimpoieş, D.G., Чимпоеш, Д., Racul, A.D., Ракул, А.
المصدر: Perspectivele şi Problemele Integrării în Spaţiul European al Cercetării şi Educaţiei (Vol.7, Partea 1)
مصطلحات موضوعية: performanţă academică, DEA, institute de cercetare, sectorul agrar, academic performance, research institutes, agronomic profile
وصف الملف: application/pdf
-
14Academic Journal
المؤلفون: S. Petrov B., V. Korol D., S. Rakul A., С. Петров Б., В. Король Д., С. Ракул А.
المصدر: Cancer Urology; Том 4, № 4 (2008); 90-91 ; Онкоурология; Том 4, № 4 (2008); 90-91 ; 1996-1812 ; 1726-9776 ; 10.17650/1726-9776-2008-4-4
وصف الملف: application/pdf
Relation: https://oncourology.abvpress.ru/oncur/article/view/1059/946; https://oncourology.abvpress.ru/oncur/article/view/1059
-
15Academic Journal
المؤلفون: S. Rakul A., С. Ракул А.
المصدر: Cancer Urology; Том 4, № 3 (2008); 57-63 ; Онкоурология; Том 4, № 3 (2008); 57-63 ; 1996-1812 ; 1726-9776 ; 10.17650/1726-9776-2008-4-3
وصف الملف: application/pdf
Relation: https://oncourology.abvpress.ru/oncur/article/view/1069/956; Велиев Е.И. Оптимизация хирургического лечения локализованных форм рака предстательной железы. Дис. … докт. мед. наук. СПб.; 2003.; Walsh P.C., Lepor H., Eggleston J.C. Radical prostatectomy with preservation of sexual function: anatomical and pathological considerations. Prostate 1983;4(5):473—85.; Tewari A., Menon M. Vattikuti Institute prostatectomy: surgical technique and current results. Curr Urol Rep 2003;4(2):119—23.; Han M., Partin A.W., Pound C.R. et al. Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15year Johns Hopkins experience. Urol Clin North Am 2001;28(3):555—65.; Tewari A., Raman J.D., Chang P. et al. Long-term survival probability in men with clinically localized prostate cancer treated either conservatively or with definitive treatment (radiotherapy or radical prostatectomy). Urology 2006;68(6):1268—74.; Freedland S.J., Isaacs W.B., Platz E.A. et al. Prostate size and risk of high-grade, advanced prostate cancer and biochemical progression after radical prostatectomy: a search database study. J Clin Oncol 2005;23(30):7546—54.; Zhou P., Chen M.-H., McLeod D. et al. Predictors of prostate cancer-specific mortality after radical prostatectomy or radiation therapy. J Clin Oncol 2005;23(28):6992—8.; Cookson M.S., Aus G., Burnett A.L. et al. Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for localized prostate cancer update panel report and recommendations for a standard in the reporting of surgical outcomes. J Urol 2007;177:540—5.; Юнкеров В.И., Григорьев С.Г. Математико-статистичекая обработка данных медицинских исследований. СПб., ВМА; 2005.; Kaplan E.L., Meier P. Nonparametric estimation from incomplete observations. J Am Statistical Association 1958;53:457—81.; https://oncourology.abvpress.ru/oncur/article/view/1069
-
16Academic Journal
المؤلفون: Traci, D., Trach, D., Трач, Д., Litvin, A., Racul, A.D., Ракул, А.
المصدر: Scientific papers. Series “Management, Economic Engineering in Agriculture and Rural Development” 449-457
مصطلحات موضوعية: agricultural enterprises, data envelopment analysis, econometric models, typology
وصف الملف: application/pdf
Relation: https://ibn.idsi.md/vizualizare_articol/210057; urn:issn:22847995
-
17Academic Journal
المؤلفون: Cimpoieş, D.G., Чимпоеш, Д., Racul, A.D., Ракул, А., Reșitca, R.
المصدر: Проблемы и вызовы экономики региона в условиях глобализации (Ediția 5, Vol.1)
وصف الملف: application/pdf
-
18Academic Journal
المؤلفون: Tomiţa, P., Racul, A.D., Ракул, А., Toma, E., Тома, Е.
المصدر: Perspectivele dezvoltării durabile a spaţiului rural în contextul noilor provocări economice (Vol.50)
مصطلحات موضوعية: data envelopment analysis, efficiency, higher education, performance, university
وصف الملف: application/pdf
-
19Academic Journal
المؤلفون: S. Rakul A., T. Kamilova A., A. Golota S., S. Shcherbak G., С. Ракул А., Т. Камилова А., А. Голота С., С. Щербак Г.
المصدر: Cancer Urology; Том 13, № 4 (2017); 111-121 ; Онкоурология; Том 13, № 4 (2017); 111-121 ; 1996-1812 ; 1726-9776 ; 10.17650/1726-9776-2017-13-4
مصطلحات موضوعية: prostate cancer, biomarker, tumoural heterogeneity, oncogene, gene-tumor suppressor, mutation, hypermethylation, microRNA, рак предстательной железы, биомаркер, опухолевая гетерогенность, генетическая гетерогенность, эпигенетическая гетерогенность, онкоген, ген-супрессор опухолей, мутация, гиперметилирование, микроРНК
وصف الملف: application/pdf
Relation: https://oncourology.abvpress.ru/oncur/article/view/776/725; Siegel R.L., Miller K.D., Jemal A. Cancer statistics, 2015. CA Cancer J Clin 2015;65(1):5–29. DOI:10.3322/caac.21254. PMID: 25559415.; Torre L.A., Bray F., Siegel R.L. et al. Global cancer statistics, 2012. CA Cancer J Clin 2015;65(2):87–108. DOI:10.3322/caac.21262. PMID: 25651787.; Saad F., Latour M., Lattouf J.B. et al. Biopsy based proteomic assay predicts risk of biochemical recurrence after radical prostatectomy. J Urol 2017;197(4):1034–40. DOI:10.1016/j.juro.2016.09.116. PMID: 27725152.; Zhang Y., Zhang P., Wan X. et al. Downregulation of long non-coding RNA HCG11 predicts a poor prognosis in prostate cancer. Biomed Pharmacother 2016;83:936–41. DOI:10.1016/j.biopha.2016.08.013. PMID: 27522256.; Attard G., Parker C., Eeles R.A. et al. Prostate cancer. Lancet 2016;387(10013):70–82. DOI:10.1016/S0140-6736(14)61947-4. PMID: 26074382.; Hjelmborg J.B., Scheike T., Holst K. et al. The heritability of prostate cancer in the Nordic Twin Study of Cancer. Cancer Epidemiol Biomarkers Prev 2014;23(11): 2303–10. DOI:10.1158/1055-9965.EPI-13-0568. PMID: 24812039.; Al Olama A.A., Kote-Jarai Z., Berndt S.I. et al. A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer. Nat Genet 2014;46(10):1103–9. DOI:10.1038/ng.3094. PMID: 25217961.; Eeles R., Goh C., Castro E. et al. The genetic epidemiology of prostate cancer and its clinical implications. Nat Rev Urol 2014;11(1):18–31. DOI:10.1038/nrurol.2013.266. PMID: 24296704.; Li L.C., Hsieh A.C., Ruggero D. et al. Molecular basis of prostate cancer. Ch. 38. The molecular basis of cancer. Eds.: J. Mendelsohn, P.M. Howley, M.A. Israel et al. 4th Edn. Philadelphia: Elsevier, 2015. 888 p.; Pritchard C.C., Mateo J., Walsh M.F. et al. Inherited DNA-repair gene mutations in men with metastatic prostate cancer. N Engl J Med 2016;375(5):443–53. DOI:10.1056/NEJMoa1603144. PMID: 27433846.; Genetics of Prostate Cancer. PDQ® Cancer Genetics Editorial Board. Bethesda, MD: NCI. Updated November 30, 2016. Available at: https://www.cancer.gov/types/prostate/hp/prostate-geneticspdq/.; Mononen N., Syrjäkoski K., Matikainen M. et al. Two percent of Finnish prostate cancer patients have a germ-line mutation in the hormone-binding domain of the androgen receptor gene. Cancer Res 2000;60(22):6479–81. PMID: 11103816.; Zheng S.L., Sun J., Wiklund F. et al. Cumulative association of five genetic variants with prostate cancer. N Engl J Med 2008;358(9):910–9. DOI:10.1056/NEJMoa075819. PMID: 18953706.; DePaolo J.S., Wang Z., Guo J. et al. Acetylation of androgen receptor by ARD1 promotes dissociation from HSP90 complex and prostate tumorigenesis. Oncotarget 2016;7(44):71417–28. DOI:10.18632/oncotarget.12163. PMID: 27659526.; Wadosky K.M., Koochekpour S. Molecular mechanisms underlying resistance to androgen deprivation therapy in prostate cancer. Oncotarget 2016;7(39):64447–70. DOI:10.18632/oncotarget.10901. PMID: 27487144.; Wong N., Major P., Kapoor A. et al. Amplification of MUC1 in prostate cancer metastasis and CRPC development. Oncotarget 2016;7(50):83115–33. DOI:10.18632/oncotarget.13073. PMID: 27825118.; Kumar A., Coleman I., Morrissey C. et al. Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancer. Nat Med 2016;22(4):369–78. DOI:10.1038/nm.4053. PMID: 26928463.; Wadosky K.M., Koochekpour S. Therapeutic rationales, progresses, failures, and future directions for advanced prostate cancer. Int J Biol Sci 2016;12(4):409–26. DOI:10.7150/ijbs.14090. PMID: 27019626.; Azad A.A., Volik S.V., Wyatt A.W. et al. Androgen receptor gene aberrations in circulating cell-free DNA: biomarkers of therapeutic resistance in castrationresistant prostate cancer. Clin Cancer Res 2015;21(10):2315–24. DOI:10.1158/1078-0432.CCR-14-2666. PMID: 25712683.; Antonarakis E.S., Lu C., Wang H. et al. AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer. N Engl J Med 2014;371(11):1028–38. DOI:10.1056/NEJMoa1315815. PMID: 26964769.; Hornberg E., Ylitalo E.B., Crnalic S. et al. Expression of androgen receptor splice variants in prostate cancer bone metastases is associated with castration-resistance and short survival. PLoS One 2011;6(4):e19059. DOI:10.1371/journal.pone.0019059. PMID: 21552559.; Turner A.R., Feng J., Liu W. et al. Prostate Cancer. Genomic and Personalized Medicine. 2nd Edn. Ch. 63. London: Academic Press, 2012. Pp. 733–741.; Haraldsdottir S., Hampel H., Wei L. et al. Prostate cancer incidence in males with Lynch syndrome. Genet Med 2014;16(7):553–7. DOI:10.1038/gim.2013.193. PMID: 24434690.; Robinson D., van Allen E.M., Wu Y.M. et al. Integrative clinical genomics of advanced prostate cancer. Cell 2015;161(5):1215–28. DOI:10.1016/j.cell.2015.05.001.; Ellingson M.S., Hart S.N., Kalari K.R. et al. Exome sequencing reveals frequent deleterious germline variants in cancer susceptibility genes in women with invasive breast cancer undergoing neoadjuvant chemotherapy. Breast Cancer Res Treat 2015;153(2):435–43. DOI:10.1007/s10549-015-3545-6. PMID: 26296701.; Leongamornlert D., Saunders E., Dadaev T. et al. Frequent germline deleterious variants in DNA repair genes in familial prostate cancer cases are associated with advanced disease. Br J Cancer 2014;110(6):1663–72. DOI:10.1038/bjc.2014.30.; Tarish F.L., Schultz N., Tanoglidi A. et al. Castration radiosensitizes prostate cancer tissue by impairing DNA double-strand break repair. Sci Transl Med 2015;7(312):312re11. DOI:10.1126/scitranslmed.aac5671. PMID: 26537259.; Polkinghorn W.R., Parker J.S., Lee M.X. et al. Androgen receptor signaling regulates DNA repair in prostate cancers. Cancer Discov 2013;3(11):1245–53. DOI:10.1158/2159-8290.CD-13-0172. PMID: 24027196.; Raison N., Elhage O., Dasgupta P. Getting personal with prostate cancer: DNA-repair defects and olaparib in metastatic prostate cancer. BJU Int 2017;119(1):8–9. DOI:10.1111/bju.13522. PMID: 27154575.; Kpetemey M., Dasgupta S., Rajendiran S. et al. MIEN1, a novel interactor of Annexin A2, promotes tumor cell migration by enhancing AnxA2 cell surface expression. Mol Cancer 2015;14:156. DOI:10.1186/s12943-015-0428-8. PMID: 26272794.; Rajendiran S., Gibbs L.D., van Treuren T. et al. MIEN1 is tightly regulated by SINE Alu methylation in its promoter. Oncotarget 2016;7(40):65307–19. DOI:10.18632/oncotarget.11675. PMID: 27589566.; Zhao S., Geybels M.S., Leonardson A. et al. Epigenome wide tumor DNA methylation profiling identifies novel prognostic biomarkers of metastatic-lethal progression in men with clinically localized prostate cancer. Clin Cancer Res 2017;23(1):311–19. DOI:10.1158/1078-0432.CCR-16-0549. PMID: 27358489.; Geybels M.S., Wright J.L., Bibikova M. et al. Epigenetic signature of Gleason score and prostate cancer recurrence after radical prostatectomy. Clin Epigenetics 2016;8:97. DOI:10.1186/s13148-016-0260-z. PMID: 27651837.; Epstein J.I., Zelefsky M.J., Sjoberg D.D. et al. A contemporary prostate cancer grading system: a validated alternative to the Gleason score. Eur Urol 2016;69(3):428–35. DOI:10.1016/j.eururo.2015.06.046. PMID: 26166626.; Singal R., Ramachandran K., Gordian E. et al. Phase I/II study of azacitidine, docetaxel, and prednisone in patients with metastatic castration-resistant prostate cancer previously treated with docetaxelbased therapy. Clin Genitourin Cancer 2015;13(1):22–31. DOI:10.1016/j.clgc.2014.07.008. PMID: 25178642.; Ayub S.G., Kaul D., Ayub T. Microdissecting the role of microRNAs in the pathogenesis of prostate cancer. Cancer Genet 2015;208(6):289–302. DOI:10.1016/j.cancergen.2015.02.010. PMID: 26004033.; Kojima S., Goto Y., Naya Y. The roles of microRNAs in the progression of castration-resistant prostate cancer. J Hum Genet 2017;62(1):25–31. DOI:10.1038/jhg.2016.69. PMID: 27278789.; Faruq O., Vecchione A. MicroRNA: diagnostic perspective. Front Med 2015;2:51. DOI:10.3389/fmed.2015.00051. PMID: 26284247.; Larne O., Östling P., Haflidadóttir B.S. et al. MiR-183 in prostate cancer cells positively regulates synthesis and serum levels of prostate-specific antigen. Eur Urol 2015;68(4):581–8. DOI:10.1016/j.eururo.2014.12.025. PMID: 25556023.; Chiyomaru T., Yamamura S., Fukuhara S. et al. Genistein inhibits prostate cancer cell growth by targeting miR-34a and oncogenic HOTAIR. PLoS One 2013;8(8):e70372. DOI:10.1371/journal.pone.0070372. PMID: 23936419.; Wang J., Shan M., Liu T. et al. Analysis of TRRAP as a potential molecular marker and therapeutic target for breast cancer. J Breast Cancer 2016;19(1):61–7. DOI:10.4048/jbc.2016.19.1.61. PMID: 27066097.; Gang X., Yang Y., Zhong J. et al. P300 acetyltransferase regulates fatty acid synthase expression, lipid metabolism and prostate cancer growth. Oncotarget 2016;7(12):15135–49. DOI:10.18632/oncotarget.7715. PMID: 26934656.; Blume-Jensen P., Berman D.M., Rimm D.L. et al. Development and clinical validation of an in situ biopsybased multimarker assay for risk stratification in prostate cancer. Clin Cancer Res 2015;21(11):2591–600. DOI:10.1158/1078-0432.CCR-14-2603. PMID: 25733599.; Shvartsur A., Bonavida B. TROP2 and its overexpression in cancers: regulation and clinical/therapeutic implications. Genes Cancer 2015;6(3–4):84–105. DOI:10.18632/genesandcancer.40. PMID: 26000093.; Trerotola M., Ganguly K.K., Fazli L. et al. Trop-2 is up-regulated in invasive prostate cancer and displaces FAK from focal contacts. Oncotarget 2015;6(16):14318–28. DOI:10.18632/oncotarget.3960. PMID: 26015409.; Ju X., Jiao X., Ertel A. et al. v-Src oncogene induces TROP2 proteolytic activation via cyclin D1. Cancer Res 2016;76(22);6723–34. DOI:10.1158/0008-5472.CAN-15-3327. PMID: 27634768.; Lin C.J., Nasr Z., Premsrirut P.K. et al. Targeting synthetic lethal interactions between Myc and the EIF-4F complex impedes tumorigenesis. Cell Rep 2012;1(4):325–33. DOI:10.1016/j.celrep.2012.02.010. PMID: 22573234.; Cencic R., Pelletier J. Hippuristanol – a potent steroid inhibitor of eukaryotic initiation factor 4A. Translation (Austin) 2016;4(1):e1137381. DOI:10.1080/21690731.2015.1137381. PMID: 27335721.; Malina A., Mills J.R., Pelletier J. Emerging therapeutics targeting mRNA translation. Cold Spring Harb Perspect Biol 2012;4(4):a012377. DOI:10.1101/cshperspect.a012377. PMID: 22474009.; Morad S.A., Schmid M., Büchele B. et al. A novel semisynthetic inhibitor of the FRB domain of mammalian target of rapamycin blocks proliferation and triggers apoptosis in chemoresistant prostate cancer cells. Mol Pharmacol 2013;83(2):531–41. DOI:10.1124/mol.112.081349. PMID: 23208958.; Nguyen P.L., Shin H., Yousefi K. et al. Impact of a genomic classifier of metastatic risk on postprostatectomy treatment recommendations by radiation oncologists and urologists. Urology 2015;86(1):35–40. DOI:10.1016/j.urology.2015.04.004. PMID: 26142578.; Ross A.E., Johnson M.H., Yousefi K. et al. Tissue-based genomics augments post-prostatectomy risk stratification in a natural history cohort of intermediateand high-risk men. Eur Urol 2016;69(1):157–65. DOI:10.1016/j.eururo.2015.05.04. PMID: 26058959.; https://oncourology.abvpress.ru/oncur/article/view/776
-
20Academic Journal
المؤلفون: S. Rakul A., K. Pozdnyakov V., R. Eloev A., N. Pliskachevskiy A., С. Ракул А., К. Поздняков В., Р. Елоев А., Н. Плискачевский А.
المصدر: Cancer Urology; Том 14, № 2 (2018); 44--53 ; Онкоурология; Том 14, № 2 (2018); 44--53 ; 1996-1812 ; 1726-9776 ; 10.17650/1726-9776-2018-14-2
مصطلحات موضوعية: renal tumor, organ-preserving treatment, robot-assisted nephron sparing, complication, новообразование почки, органсохраняющее лечение, робот-ассистированная резекция почки, лапароскопическая радикальная нефрэктомия, осложнения
وصف الملف: application/pdf
Relation: https://oncourology.abvpress.ru/oncur/article/view/785/763; Jemal A., Bray F., Centr M.M. et al. Global cancer statistics. CA Cancer J Clin 2011;61(2):69–90. DOI:10.3322/caac.20107. PMID: 21296855.; Ferlay J., Soerjomataram I., Dikshit R. et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015;136(5):E359–86. DOI:10.1002/ijc.29210. PMID: 25220842.; Злокачественные новообразования в России в 2015 году (заболеваемость и смертность). Под ред. А.Д. Каприна, В.В. Старинского, Г.В. Петровой. М.: МНИОИ им. П.А. Герцена – филиал ФГБУ «НМИРЦ» Минздрава России, 2017. 250 с.; Huang W.C., Elkin E.B., Levey A.S. et al. Partial nephrectomy versus radical nephrectomy in patients with small renal tumors – is there a difference in mortality and cardiovascular outcomes? J Urol 2009;181(1):55–61. DOI:10.1016/j.juro.2008.09.017. PMID: 19012918.; Kates M., Badalato G.M., Pitman M., McKiernan J.M. Increased risk of overall and cardiovascular mortality after radical nephrectomy for renal cell carcinoma 2 cm or less. J Urol 2011;186(4):1247–53. DOI:10.1016/j.juro.2011.05.054. PMID: 21849201.; Miller D.C., Schonlau M., Litwin M.S. et al. Renal and cardiovascular morbidity after partial or radical nephrectomy. Cancer 2008;112(3):511–20. DOI:10.1002/cncr.23218. PMID: 18072263.; Kutikov A., Smaldone M.C., Uzzo R.G. Partial versus radical nephrectomy: balancing nephrons and perioperative risk. Eur Urol 2013;64(4):607–9. DOI:10.1016/j.eururo.2013.01.020. PMID: 23375430.; Kaushik D., Kim S.P., Childs M.A. et al. Overall survival and development of stage IV chronic kidney disease in patients undergoing partial and radical nephrectomy for benign renal tumors. Eur Urol 2013;64(4):600–6. DOI:10.1016/j.eururo.2012.12.023. PMID: 23280319.; Ljungberg B., Hanbury D.C., Kuczyk M.A. et al. Renal cell carcinoma guideline. Eur Urol 2007;51(6):1502–10. DOI:10.1016/j.eururo.2007.03.035. PMID: 17408850.; Campbell S., Uzzo R.G., Allaf M.E. et al. Renal mass and localized renal cancer: AUA guideline. J Urol 2017;198(3):520–9. DOI:10.1016/j.juro.2017.04.100. PMID: 28479239.; Лоран О.Б., Серегин А.В., Шустицкий Н.А. Технические особенности при выполнении органосохраняющих операций по поводу рака почки. Медицинский вестник Башкортостана 2013;8(2):197–201. [; Волкова М.И., Скворцов И.Я., Климов А.В. и др. Влияние объема хирургического вмешательства на функциональные результаты и кардиоспецифическую выживаемость у больных клинически локализованным раком почки. Онкоурология 2014;(3):22–30. [; Алексеев Б.Я., Анжиганова Ю.В., Лыков А.В. и др. Особенности диагностики и лечения рака почки в России: предварительные результаты многоцентрового кооперированного исследования. Онкоурология 2012(3):24–30.; Clavien P.A., Barkun J., de Oliveira M.L. et al. The Clavien–Dindo classification of surgical complications: five year experience. Ann Surg 2009;250(2):187–96. DOI:10.1097/SLA.0b013e3181b13ca2. PMID: 19638912.; Olbert P.J., Maier M., Heers H. et al. Indications for nephron-sparing surgery. Analysis over a 13-year period in the context of changing guidelines. Urologe A 2015;54(6):804–10. DOI:10.1007/s00120-014-3710-2. PMID: 25503720.; Minervini A., Vittori G., Antonelli A. et al. Open versus robotic-assisted partial nephrectomy: a multicenter comparison study of perioperative results and complications. World J Urol 2014;32(1):287–93. DOI:10.1007/s00345-013-1136-x. PMID: 23913095.; Sun M., Abdollah F., Shariat S.F. et al. Propensity-score matched comparison of complications, blood transfusions, length of stay, and in-hospital mortality between open and laparoscopic partial nephrectomy: a national series. Eur J Surg Oncol 2012;38(1):80–7. DOI:10.1016/j.ejso.2011.09.035. PMID: 21996370.; Hadjipavlou M., Khan F., Fowler S. et al. Partial vs radical nephrectomy for T1 renal tumours: an analysis from the British Association of Urological Surgeons Nephrectomy Audit. BJU Int 2015;117(1):62–71. DOI:10.1111/bju.13114. PMID: 25754386.; Autorino R., Zargar H., Butler S. et al. Incidence and risk factors for 30-day readmission in patients undergoing nephrectomy procedures: a contemporary analysis of 5276 cases from the National Surgical Quality Improvement Program database. Urology 2015;85(4):843–9. DOI:10.1016/j.urology.2014.11.044. PMID: 25681252.; Meyer C., Hansen J., Becker A. et al. The adoption of nephron-sparing surgery in Europe – a trend analysis in two referral centers from Austria and Germany. Urol Int 2016;96(3):330–6. DOI:10.1159/000442215. PMID: 26699625.; Lista G., Buffi N.M., Lughezzani G. et al. Margin, ischemia, and complications system to report perioperative outcomes of robotic partial nephrectomy: a European Multicenter Observational Study (EMOS project). Urology 2015;85(3):589–95. DOI:10.1016/j.urology.2014.09.068. PMID: 25733270.; Mathieu R., Verhoest G., Droupy S. et al. Predictive factors of complications after robot-assisted laparoscopic partial nephrectomy: a retrospective multicentre study. BJU Int 2013;112(4):E283–9. DOI:10.1111/bju.12222. PMID: 23879913.; Nogueira L., Katz D., Pinochet R. et al. Critical evaluation of perioperative complications in laparoscopic partial nephrectomy. Urology 2010;75(2):288–94. DOI:10.1016/j.urology.2009.09.036. PMID: 19963244.; Alemozaffar M., Chang S.L., Kacker R. et al. Comparing costs of robotic, laparoscopic, and open partial nephrectomy. J Endourol 2013;27(5):560–5. DOI:10.1089/end.2012.0462. PMID: 23130756.; Mano R., Schulman A., Hakimi A.A. et al. Cost comparison of open and robotic partial nephrectomy using a short postoperative pathway. Urology 2015;85(3):596– 603. DOI:10.1016/j.urology.2014.10.044. PMID: 25586478.; https://oncourology.abvpress.ru/oncur/article/view/785